Please login to the form below

Not currently logged in
Email:
Password:

Boehringer appoints new chairman of the board

Hubertus vonBaumbach will succeed Andreas Barner
Hubert von Baumbach

Boehringer Ingelheim has appointed Hubertus von Baumbach as chairman of the board of managing directors with effect from June 2016.

Baumbach has been a member of the board of managing directors since 2009 and is head of the corporate board division of finance. He has also worked at Roche in the US and at Boehringer Ingelheim in Canada.

His appointment follows the move of the current chair, Andreas Barner, to the shareholders' committee.

Christian Boehringer, chair of the shareholders' committee, said: “This decision provided a successor who would ensure continuity whilst also looking to the future. Hubertus von Baumbach knows the corporation and its various divisions and his time on the board of managing directors has prepared him well for the company's future challenges.   

"Along with colleagues on the board of managing directors, he will continue the drive for change at Boehringer Ingelheim in order to secure the company's independence in the long term.”  

Also joining the board is Michel Pairet who will be responsible for the corporate business division of research and nonclinical development from January 1 2016. He formerly led the pharmacology unit at the research facility in Biberach

Article by
Nikhil Patel

9th November 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics